COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,577 Articles (22,415 medRxiv, 8,162 bioRxiv)

Most recent first Previous |  Page 2171: Articles 21701-21710  | Next

Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
Van Walle, I., Leitmeyer, K., Broberg, E. K., The European COVID-19 microbiological laboratories group
10.1101/2020.09.16.20195917 — Posted: 2020-09-18
Ranking the relative importance of COVID-19 immunisation strategies: a survey of expert stakeholders in Canada
Zhao, L., Ismail, S. J., Tunis, M. C.
10.1101/2020.09.16.20196295 — Posted: 2020-09-18
Disparities in COVID-19 Related Mortality in U.S. Prisons and the General Population
Nowotny, K. M., Cloud, D., Wurcel, A. G., Brinkley-Rubinstein, L.
10.1101/2020.09.17.20183392 — Posted: 2020-09-18 Discussion: Offsite
COVID-19 pediatric mortality rates are heterogenous between countries
Gonzalez-Garcia, N., Miranda-Lora, A. L., Mendez-Galvan, J., Granados-Riveron, J. T., Nieto-Zermeno, J., Garduno-Espiosa, J., CASTILLA-PEON, M. F.
10.1101/2020.09.17.20196832 — Posted: 2020-09-18
Seroprevalence of Antibodies to SARS-CoV-2 in US Blood Donors
Vassallo, R. R., Bravo, M. D., Dumont, L. J., Hazegh, K., Kamel, H.
10.1101/2020.09.17.20195131 — Posted: 2020-09-18
Urban rail transport and SARS-CoV-2 infections: an ecological study in Lisbon Metropolitan Area
Severo, M., Ribeiro, A. I., Lucas, R., Leao, T., Barros, H.
10.1101/2020.09.18.20195776 — Posted: 2020-09-18
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
Axfors, C., Schmitt, A. M., Janiaud, P., van 't Hooft, J., Abd-Elsalam, S., Abdo, E. F., Abella, B. S., Akram, J., Amaravadi, R. K., Angus, D. C., Arabi, Y. M., Azhar, S., Baden, L. R., Baker, A. W., Belkhir, L., Benfield, T., Berrevoets, M. A. H., Chen, C.-P., Chen, T.-C., Cheng, S.-H., Cheng, C.-Y., Chung, W.-S., Cohen, Y. Z., Cowan, L. N., Dalgard, O., de Almeida e Val, F. F., de Lacerda, M. V. G., de Melo, G. C., Derde, L., Dubee, V., Elfakir, A., Gordon, A. C., Hernandez-Cardenas, C. M., Hills, T., Hoepelman, A. I. M., Huang, Y.-W., Igau, B., Jin, R., Jurado-Camacho, F., Khan, K. S., Kremsner, P. G., Kreuels, B., Kuo, C.-Y., Le, T., Lin, Y.-C., Lin, W.-P., Lin, T.-H., Nakrem Lyngbakken, M., McArthur, C., McVerry, B., Meza-Meneses, P., Monteiro, W. M., Morpeth, S. C., Mourad, A., Mulligan, M. J., Murthy, S., Naggie, S., Narayanasamy, S., Nichol, A., Novack, L. A., O'Brien, S. M., Okeke, N. L., Perez, L., Perez-Padilla, R., Perrin, L., Remigio-Luna, A., Rivera-Martinez, N. E., Rockhold, F. W., Rodriguez-Llamazares, S., Rolfe, R., Rosa, R., Rosjo, H., Sampaio, V. S., Seto, T. B., Shehzad, M., Soliman, S., Stout, J. E., Thirion-Romero, I., Troxel, A. B., Tseng, T.-Y., Turner, N. A., Ulrich, R. J., Walsh, S. R., Webb, S. A., Weehuizen, J. M., Velinova, M., Wong, H.-L., Wrenn, R., Zampieri, F. G., Zhong, W., Moher, D., Goodman, S. N., Ioannidis, J. P. A., Hemkens, L. G.
10.1101/2020.09.16.20194571 — Posted: 2020-09-18 Discussion: Onsite
The impact of vital signs on the death of patients with new coronavirus pneumonia: A systematic review and meta-analysis
Du, M., Zhao, J., Yin, X., Zhang, N., Zheng, G.
10.1101/2020.09.17.20196709 — Posted: 2020-09-18
Cost-effective serological test to determine exposure to SARS-CoV-2: ELISA based on the receptor-binding domain of the spike protein (Spike-RBDN318-V510) expressed in Escherichia coli
Marquez-Ipina, A. R., Gonzalez-Gonzalez, E., Rodriguez-Sanchez, I. P., Lara-Mayorga, I. M., Mejia-Manzano, L. A., Gonzalez-Valdez, J. G., Ortiz-Lopez, R., Rojas-Martinez, A., Trujillo-de Santiago, G., Alvarez, M. M.
10.1101/2020.09.15.20195503 — Posted: 2020-09-18
Model-based and model-free characterization of epidemic outbreaks
Dehning, J., Spitzner, F. P., Linden, M. C., Mohr, S. B., Pinheiro Neto, J., Zierenberg, J., Wibral, M., Wilczek, M., Priesemann, V.
10.1101/2020.09.16.20187484 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).